Warning Letter Roundup: FDA Targets Firms for GMP, Other Violations

Drug GMP Report
A A
The FDA issued warning letters to eight drug manufacturers for adulterated products, misbranding and unapproved drug products, among other violations.

To View This Article:

Login

Subscribe To Drug GMP Report